Reaxa to launch new product-saving scavenging resins

By Emilie Reymond

- Last updated on GMT

Related tags Reaxa

Reaxa has chose the recent CphI to announce it is developing a new
addition to its range of scavenging resins that it claims allows a
huge reduction in product loss in the process of precious metals

The new product is the first from the QuadraPure scavenging resins range to be available in ready-to-use cartridge format. It is designed to remove contaminants - residual metals and organic impurities - from synthetic products and waste streams.

Reaxa claims its pre-loaded macroporous cartridges will deliver product clean-up, achieving target toxic metal levels on a single pass, with less than one per cent loss of product.

"This compares with typically reported 10-15 per cent loss of product using traditional carbon clean-up,"​ said the firm.

In addition, the firm claims that other benefits of using cartridge filtration include a large reduction in solvent usage and a major reduction in metal contaminated waste - all of which is concentrated on the resin and retained in the cartridge.

"Cartridge-format scavenging promises to bring a step chance in process re-engineering and play a major role in securing performance, cost and environmental compliance targets in the next generation of high-performance pharma production systems,"​ said Pete Jackson, Reaxa CEO.

UK-based Reaxa has been working with filtration specialist Clear Edge on the product development and two sizes of pre-loaded cartridges are being developed with the smaller units already available for use in early phase applications.

The firm already has a range of 10 macroporous and microporous QuadraPure metal scavenging resins.

By expanding the range of products, the latest QuadraPure scavengers extend clean-up performance to solve a wider range of metal contamination problems in pharma processing, said the firm.

Related news

Show more

Related products

Efficient Freezing & Storage of Biopharmaceuticals

Efficient Freezing & Storage of Biopharmaceuticals

Content provided by Single Use Support | 06-Nov-2023 | White Paper

Various options exist for freezing biopharmaceutical bulk material, but selecting the most effective and efficient approach for each cold chain can be...

Follow us